January 19, 2023
January 19, 2023 - Seagen Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tukysa
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
News
January 17, 2023
FDA Approves Adacel for Immunization During Pregnancy to Help Protect Young
Infants Against Pertussis
January 17, 2023 - The U.S. Food and Drug Administration (FDA) has approved Adacel (Tetanus Toxoid,
Reduced Diphtheria Toxoid and Acellular Pertussis
January 15, 2023
January 15, 2023 - Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale
January 13, 2023
January 13, 2023 – The FDA signed the Agreement on Mutual Recognition between the Swiss Confederation and the U.S. Relating to Pharmaceutical Good Manufacturing Practice.
January 12, 2023
January 12, 2023 - The FDA has approved a label update for Rybelsus (semaglutide) tablets 7 mg or 14 mg, allowing use as a first-line treatment option for adults
January 11, 2023
January 11, 2023 - Airsupra (albuterol/budesonide), formerly known as PT027, has been approved in the
US for the as-needed treatment or prevention
January 6, 2023
January 6, 2023 - The U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb)
January 3, 2023
Jan. 3, 2023 -- Prophylactic use of methylprednisolone does not reduce the likelihood of a worse
outcome for infants undergoing surgery with cardiopulmonary bypass